1268810-13-4 Usage
Description
(Cyclobutylethynyl)triMethylsilane is an organosilicon compound with the chemical formula C9H16Si, consisting of a cyclobutyl group bonded to an ethynyl group and three methyl groups attached to a silicon atom. It is known for its ability to form carbon-carbon bonds through its reactive triple bond, making it useful in various chemical reactions.
Uses
Used in Pharmaceutical Industry:
(Cyclobutylethynyl)triMethylsilane is used as a reagent in the pharmaceutical industry for its ability to form carbon-carbon bonds, which is crucial in the synthesis of various pharmaceutical compounds.
Used in Chemical Synthesis:
(Cyclobutylethynyl)triMethylsilane is used as a reagent in chemical synthesis for its ability to form carbon-carbon bonds, making it useful in the production of specialty chemicals and materials.
Used in Material Production:
(Cyclobutylethynyl)triMethylsilane is used as a reagent in the production of specialty materials, where its ability to form carbon-carbon bonds is essential for creating unique material properties.
Safety Precautions:
It is important to handle (cyclobutylethynyl)triMethylsilane with care, as it is flammable and can be harmful if ingested, inhaled, or in contact with the skin. Proper safety measures should be taken during its use and storage to prevent accidents and health risks.
Check Digit Verification of cas no
The CAS Registry Mumber 1268810-13-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,8,8,1 and 0 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1268810-13:
(9*1)+(8*2)+(7*6)+(6*8)+(5*8)+(4*1)+(3*0)+(2*1)+(1*3)=164
164 % 10 = 4
So 1268810-13-4 is a valid CAS Registry Number.
1268810-13-4Relevant articles and documents
TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE
-
, (2016/12/22)
Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast cancer may be an ER-positive breast cancer and/or the subject in need of treatment may express a mutant ER-α protein.
ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
-
Paragraph 00513, (2013/10/08)
Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.
Productive syntheses of 1-ethynylcyclopropylamine and 1- ethynylcyclobutylamine
Kozhushkov, Sergei I.,Wagner-Gillen, Karsten,Khlebnikov, Alexander F.,Demeijere, Armin
experimental part, p. 3967 - 3973 (2011/02/22)
The new 1,1-dimethylpropargylamine surrogates, 1-ethynylcyclopropylamine (3) and 1-ethynylcyclobutylamine (5), were prepared as hydrochlorides from cyclopropylacetylene and 6-chlorohex-1-yne in overall yields of 39 and 25%, respectively, on a scale of up to 300 mmol. The amine 3 was converted into the new ethynyl-extended 1-aminocyclopropanecarboxylic acid 4, and both the amine 3 as well as the amino acid 4 were made available as their N-Fmoc-protected derivatives. Georg Thieme Verlag Stuttgart - New York.
